Academic Journals Database
Disseminating quality controlled scientific knowledge

PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells

ADD TO MY LIST
 
Author(s): Zhang Tong | Huang Xian-Hong | Dong Lan | Hu Deqing | Ge Changhui | Zhan Yi-Qun | Xu Wang-Xiang | Yu Miao | Li Wei | Wang Xiaohui | Tang Liujun | Li Chang-Yan | Yang Xiao-Ming

Journal: Molecular Cancer
ISSN 1476-4598

Volume: 9;
Issue: 1;
Start page: 72;
Date: 2010;
Original page

ABSTRACT
Abstract Background PCBP1 (or alpha CP1 or hnRNP E1), a member of the PCBP family, is widely expressed in many human tissues and involved in regulation of transcription, transportation process, and function of RNA molecules. However, the role of PCBP1 in CD44 variants splicing still remains elusive. Results We found that enforced PCBP1 expression inhibited CD44 variants expression including v3, v5, v6, v8, and v10 in HepG2 cells, and knockdown of endogenous PCBP1 induced these variants splicing. Invasion assay suggested that PCBP1 played a negative role in tumor invasion and re-expression of v6 partly reversed the inhibition effect by PCBP1. A correlation of PCBP1 down-regulation and v6 up-regulation was detected in primary HCC tissues. Conclusions We first characterized PCBP1 as a negative regulator of CD44 variants splicing in HepG2 cells, and loss of PCBP1 in human hepatic tumor contributes to the formation of a metastatic phenotype.
Save time & money - Smart Internet Solutions      Why do you need a reservation system?